Publication Highlights

31 Jul 2022

Dystrophin expression comparison in CXMD dog model

21 Jun 2022

Type I interferon in dermatomyositis: Impact on myogenesis and possible autocrine/paracrine effect

19 May 2022

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy

21 Apr 2022

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice

14 Mar 2022

Assessing dysferlinopathy patients over three years with a new motor scale

10 Jan 2022

Exploring new therapeutic approaches in FSHD by small molecules modulation of endogenous microRNA

06 Dec 2021

An alternative to corticosteroid for the treatment of Duchenne Muscular Dystrophy

01 Nov 2021

Demonbreun et al identify a novel antibody mediated therapeutic strategy for Duchenne muscular dystrophy based on previous genetic modifier studies.

01 Oct 2021

Severe COVID-19 is associated with post-infectious inflammatory myopathy

02 Sep 2021

Establishing the validity of motor outcome measures in young boys with Duchenne Muscular Dystrophy is critical for the success of future trials

02 Aug 2021

Exploring myonuclear heterogeneity and compartmentalization of muscle fiber...

01 Jul 2021

Distinctive features of LRP12-oculopharyngeal muscular dystrophy

04 Jun 2021

Evidence of functionality of induced dystrophin following therapeutic intervention in Duchenne patient

Page 1 of 1, showing 13 records out of 13 total.

WMS Twitter Feed
WMS Facebook Feed